Afrezza® INHALE-1 Study in Pediatrics

NCT04974528 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

319

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2

Interventions

BIOLOGICAL: Afrezza
BIOLOGICAL: Rapid-acting Insulin Analog
BIOLOGICAL: Basal Insulin

Sponsor

Mannkind Corporation

Collaborators

[object Object]